Table of Contents
Executive Summary — 5
SWOT
Analysis — 7
Uzbekistan Pharmaceuticals And Healthcare
Industry SWOT — 7
Pharmaceutical Business Environment
Ratings — 8
Table: Central And Eastern Europe
Pharmaceuticals Business Environment Ratings — 8
Limits To
Potential Returns — 9
Risks To Realisation Of
Returns — 9
Uzbekistan – Market
Summary — 11
Regulatory Regime — 13
Counterfeit Drugs — 13
Intellectual Property
Rights — 15
Pricing and
Reimbursement — 15
Industry
Developments — 17
Epidemiology — 17
Healthcare Sector — 18
Healthcare Sector
Reforms — 20
Pharmaceutical
Industry — 20
Pharmaceutical Sector
Reforms — 21
Pharmaceutical Industry
Developments — 22
Pharmaceutical Wholesale and
Retail — 23
Research and
Development — 24
International
Co-operation — 24
Medical Devices — 25
Industry Forecast Scenario — 26
Overall Market
Forecast — 26
Table: Uzbekistan’s Drug Market
Expenditure, 2003-2013 — 27
Key Growth Factors –
Industry — 28
Table: Uzbekistan’s Health
Expenditure, 2003-2013 (UZS mn unless otherwise
stated) — 29
Key Growth Factors –
Macroeconomic — 30
Table: Uzbekistan - Economic Activity,
2006-2013 — 31
Prescription Drug Market
Forecast — 32
Table: Uzbekistan’s Prescription Drug
Market, 2004-2013 (US$mn unless otherwise stated) — 33
Top
Ten ATC Level 2 Codes In Uzbekistan By Sales,
2007-2008 — 34
Patented Drug Market
Forecast — 35
Table: Uzbekistan’s Patented Drug
Market, 2003-2013 — 36
Generic Drug Market
Forecast — 37
Table: Uzbekistan’s Generic Drug
Market, 2003-2013 (UZSmn unless otherwise stated) — 37
OTC
Drug Market Forecast — 38
Table: Uzbekistan’s OTC
Market, 2003-2013 (US$mn unless otherwise stated) — 39
Pharmaceutical Export/Import Forecast — 40
Table:
Uzbekistan’s Pharmaceutical Trade Balance, 2003-2013
(US$mn) — 40
Other Healthcare Data
Forecasts — 41
Table: Uzbekistan’s Other Health
Indicators, 2003-2013 — 41
Key Risks to BMI’s
Forecasts — 41
Competitive
Landscape — 43
The Top Ten Drugmakers In Uzbekistan During
2007/08 According To Sales — 43
The Top Ten Trade Names In
Uzbekistan During 2007/08 According To Sales — 44
Table:
Top 10 INNs and Combinations In Uzbekistan During 2007/2008 According To
Sales — 44
Company Profiles — 45
Indigenous Companies — 45
Jurabek
Laboratories — 45
Uzpharmsanoat — 47
Asklepiy Pharmaceutical Company — 49
BMI
Methodology — 50
How We Generate Our Pharmaceutical
Industry Forecasts — 50
Pharmaceutical Business
Environment Ratings Methodology — 51
Ratings
Overview — 51
Table: Pharmaceutical Business Environment
Indicators — 52
Weighting — 53
Table:
Weighting Of Components — 53
Sources — 53
| 
View Cart
